AmeriFlex Group
HELP

AmeriFlex Group’s Helus Pharma Inc. Common Stock HELP Stock Holding History

AmeriFlex Group’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$866 Hold
131
– – ﹤0.01% 1444
2026
Q1 		$629 Hold
131
– – ﹤0.01% 1012
2025
Q4 		$1.07K Buy
+131
New +$843 ﹤0.01% 1029
2025
Q2 		– Sell
-131
Closed -$831 – 1106
2025
Q1 		$831 Buy
+131
New +$1.13K ﹤0.01% 1216

Other funds holding HELP

VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Rosalind Advisors
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Sphera Funds Management
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Sio Capital Management
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Nan Fung Group Holdings
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

AmeriFlex Group's HELP Position: Q2 2026 in Review

AmeriFlex Group held its Helus Pharma Inc. Common Stock (HELP) position steady in Q2 2026 at 131 shares worth $866. The position accounts for ﹤0.01% of the portfolio, ranked #1444.

AmeriFlex Group first reported a position in HELP in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.07K in Q4 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • AmeriFlex Group held 131 shares of Helus Pharma Inc. Common Stock worth $866 as of Q2 2026.
  • AmeriFlex Group left its Helus Pharma Inc. Common Stock share count unchanged in Q2 2026.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1444 holding.
  • AmeriFlex Group first reported a position in Helus Pharma Inc. Common Stock in Q1 2025 and has held it in 4 quarters since.
  • AmeriFlex Group's Helus Pharma Inc. Common Stock position peaked at $1.07K in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.